Magnocavallo, Michele
 Distribuzione geografica
Continente #
NA - Nord America 582
EU - Europa 338
AS - Asia 156
SA - Sud America 5
AF - Africa 2
OC - Oceania 1
Totale 1.084
Nazione #
US - Stati Uniti d'America 575
IT - Italia 191
SG - Singapore 91
SE - Svezia 59
IN - India 47
BG - Bulgaria 20
FI - Finlandia 19
DE - Germania 11
RO - Romania 9
IE - Irlanda 7
HK - Hong Kong 6
TH - Thailandia 6
AR - Argentina 5
NL - Olanda 5
CA - Canada 4
CN - Cina 4
PL - Polonia 4
FR - Francia 3
GB - Regno Unito 3
UA - Ucraina 3
ES - Italia 2
MX - Messico 2
TG - Togo 2
DO - Repubblica Dominicana 1
ID - Indonesia 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.084
Città #
Rome 85
Ashburn 82
Singapore 62
Chandler 61
Fairfield 59
Princeton 32
San Paolo di Civitate 24
Millbury 23
Wilmington 21
Seattle 20
Sofia 20
Helsinki 18
Stockholm 18
Woodbridge 15
San Diego 14
Lawrence 13
Andover 12
Houston 12
Cambridge 11
Pune 11
New York 10
Milan 9
Santa Clara 9
Boardman 7
Dublin 7
Hong Kong 6
Amsterdam 5
Dallas 5
Federal 5
Redwood City 5
Bologna 4
Norwalk 4
San Mateo 4
Straubenhardt 4
Toronto 4
Boston 3
Bühl 3
Guidonia Montecelio 3
Lariano 3
Matera 3
Ann Arbor 2
Barcelona 2
Biancavilla 2
Buffalo 2
Cagliari 2
Camponogara 2
Civitavecchia 2
Corteno Golgi 2
Fermignano 2
Fremont 2
Guardavalle 2
Laxou 2
Lomé 2
Mountain View 2
Palermo 2
Perugia 2
Sacramento 2
Accadia 1
Auckland 1
Austin 1
Azcapotzalco 1
Bangalore 1
Bari 1
Bergamo 1
Bratislava 1
Bussolengo 1
Catania 1
Chennai 1
Figline Valdarno 1
Frankfurt am Main 1
Fubine 1
Gela 1
Hangzhou 1
Jakarta 1
Lappeenranta 1
Las Vegas 1
London 1
Los Angeles 1
Marano Di Napoli 1
Marino 1
Milazzo 1
Munich 1
Mykolayiv 1
Oxford 1
Plattsmouth 1
Recanati 1
Redmond 1
Richmond 1
San Pablo 1
Santo Domingo Este 1
Serra D'aiello 1
Shanghai 1
Shenzhen 1
Strumica 1
Verona 1
Vijayawada 1
Villanova 1
Wandsworth 1
Totale 791
Nome #
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis 60
Management of cardiac implantable electronic device follow-up in COVID-19 pandemic. Lessons learned during Italian lockdown 57
Flecainide how and when. a practical guide in supraventricular arrhythmias 57
Home delivery of the communicator for remote monitoring of cardiac implantable devices: a multicenter experience during the covid-19 lockdown 47
Potential role of eNOS genetic variants in ischemic heart disease susceptibility and clinical presentation 47
Adverse drug reactions during real-life use of direct oral anticoagulants in italy. An update based on data from the italian national pharmacovigilance network 45
Clinical presentation, diagnosis, and treatment of atrioesophageal fistula resulting from atrial fibrillation ablation 45
Flecainide in ventricular arrhythmias. from old myths to new perspectives 45
Evidence of systemic endothelial injury and microthrombosis in hospitalized COVID-19 patients at different stages of the disease 44
Thromboembolic and bleeding risk in atrial fibrillation patients with chronic kidney disease: role of anticoagulation therapy 38
Sporadic high pacing and shock impedance on remote monitoring in hybrid implantable cardioverter-defibrillator systems: clinical impact and management 35
Prevalence and clinical Implications of COVID-19 myocarditis 34
The scar. the wind in the perfect storm-insights into the mysterious living tissue originating ventricular arrhythmias 33
New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulation 33
Incidence of Device-Related Thrombosis in Watchman Patients Undergoing a Genotype-Guided Antithrombotic Strategy 32
A mobile app for improving the compliance with remote management of patients with cardiac implantable devices. a multicenter evaluation in clinical practice 32
Radiofrequency Energy Applications Targeting Significant Residual Leaks After Watchman Implantation: A Prospective, Multicenter Experience 31
Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion 30
Left atrial appendage exclusion in atrial fibrillation radiofrequency ablation during mitral valve surgery: a single-center experience 29
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy 28
Clinical Support through Telemedicine in Heart Failure Outpatients during the COVID-19 Pandemic Period: Results of a 12-Months Follow Up 27
Reply to the editor-high subthreshold pacing impedance from device-lead connection issues 25
Impact of COVID-19 pandemic on cardiac electronic device management and role of remote monitoring 25
Predictive value of measures of vascular calcification burden and progression for risk of death in incident to dialysis patients 20
Catheter ablation of life-threatening ventricular arrhythmias in athletes 20
The scar: the wind in the perfect storm—insights into the mysterious living tissue originating ventricular arrhythmias 20
Procedural and Short-Term Follow-Up Outcomes of Amplatzer Amulet Occluder versus Watchman FLX Device: A Meta-Analysis 19
Targeting non-pulmonary vein triggers in persistent atrial fibrillation: results from a prospective, multicentre, observational registry 18
Catheter Ablation For Papillary Muscle Arrhythmias A Systematic Review 18
[Atrial fibrillation, oral anticoagulation and nephroprotection: caution or bravery?] 18
Ventricular electrograms duration map to detect ventricular arrhythmia substrate. the VEDUM project study 18
A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy 16
Prevalence, management, and outcome of atrial fibrillation and other supraventricular arrhythmias in COVID-19 patients 16
Long-Term Clinical-Pathologic Results of Enzyme Replacement Therapy in Prehypertrophic Fabry Disease Cardiomyopathy 15
Clinical Support through Telemedicine in Heart Failure Outpatients during the COVID-19 Pandemic Period: Results of a 12-Months Follow Up 15
null 15
null 15
null 14
null 13
Zero-Contrast Left Atrial Appendage Occlusion and Peridevice Leak Closure in Patients with Advanced Kidney Disease 12
Vascular Calcification Progression Modulates the Risk Associated with Vascular Calcification Burden in Incident to Dialysis Patients 12
null 11
Rationale and study design of the Italian Registry in the setting of atrial fibrillation ablation with Rivaroxaban - IRIS 6
Modified sympathicotomy in patients with refractory ventricular tachycardia and structural heart disease: a single-center experience 3
Totale 1.193
Categoria #
all - tutte 6.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.200


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 0 0 3 12 19 4 15
2021/2022350 5 1 21 53 23 24 8 52 38 14 56 55
2022/2023329 59 53 9 20 38 24 19 21 45 12 25 4
2023/2024326 16 37 15 35 40 79 8 22 0 23 31 20
2024/2025135 29 65 41 0 0 0 0 0 0 0 0 0
Totale 1.193